1. Home
  2. GANX vs DVLT Comparison

GANX vs DVLT Comparison

Compare GANX & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • DVLT
  • Stock Information
  • Founded
  • GANX 2017
  • DVLT 2010
  • Country
  • GANX United States
  • DVLT United States
  • Employees
  • GANX N/A
  • DVLT N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • DVLT
  • Sector
  • GANX Health Care
  • DVLT
  • Exchange
  • GANX Nasdaq
  • DVLT NYSE
  • Market Cap
  • GANX 53.8M
  • DVLT 55.7M
  • IPO Year
  • GANX 2021
  • DVLT N/A
  • Fundamental
  • Price
  • GANX $1.72
  • DVLT $0.71
  • Analyst Decision
  • GANX Strong Buy
  • DVLT Strong Buy
  • Analyst Count
  • GANX 5
  • DVLT 1
  • Target Price
  • GANX $8.20
  • DVLT $3.00
  • AVG Volume (30 Days)
  • GANX 299.5K
  • DVLT 563.6K
  • Earning Date
  • GANX 08-07-2025
  • DVLT 08-13-2025
  • Dividend Yield
  • GANX N/A
  • DVLT N/A
  • EPS Growth
  • GANX N/A
  • DVLT N/A
  • EPS
  • GANX N/A
  • DVLT N/A
  • Revenue
  • GANX N/A
  • DVLT $3,048,000.00
  • Revenue This Year
  • GANX N/A
  • DVLT $434.03
  • Revenue Next Year
  • GANX N/A
  • DVLT $221.43
  • P/E Ratio
  • GANX N/A
  • DVLT N/A
  • Revenue Growth
  • GANX N/A
  • DVLT 63.08
  • 52 Week Low
  • GANX $0.89
  • DVLT $0.60
  • 52 Week High
  • GANX $3.19
  • DVLT $3.25
  • Technical
  • Relative Strength Index (RSI)
  • GANX 49.29
  • DVLT N/A
  • Support Level
  • GANX $1.55
  • DVLT N/A
  • Resistance Level
  • GANX $1.79
  • DVLT N/A
  • Average True Range (ATR)
  • GANX 0.16
  • DVLT 0.00
  • MACD
  • GANX -0.00
  • DVLT 0.00
  • Stochastic Oscillator
  • GANX 44.53
  • DVLT 0.00

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About DVLT DATAVAULT AI INC

Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.

Share on Social Networks: